Fritextsökning
Innehållstyper
-
Framgång för pausgympa
Ta en paus och rör på dig - det har Healthtechbolaget Pausit tagit fasta på och når nu 125 000 människor i Sverige med sitt gympaprogram på datorn.
-
Happy exhibitors!
There were fewer vistors this year but most exhibitors are content.
-
Bildar fastighetsbolag för life science
Nytt bolag ska bland annat utveckla lokaler för Nya Karolinska Sjukhuset och Sahlgrenska Universitetssjukhuset.
-
Fastighetsbolag stöttar antibiotika-startup
Umeåbolaget Quretech bio tar in sin första externa investerare – den lokala aktören Nordiska centrumhus.
-
Abbott expands by acquisition
An acquisition gives Abbott a leadership position in another large and growing medical device segment.
-
Virusforskare får Scilifelabpris
Forskningsinstitutet delar i samarbete med tidskriften Science ut pris till unga forskare.
-
International models among science parks
Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Cou...
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
-
Enzymatisk upprening av PCR-reaktioner
HT Exosap-IT Fast är ett reagens som i ett pipetteringssteg tillåter upprening av PCR-reaktioner.
-
De ska basa över Scilifelab
I dag tog regeringen beslut om hur forskningscentrumet Scilifelab ska styras.
-
Martin Bergö: "The Idea is the Thing"
Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...
-
Läkemedelsrening behöver inte vara dyr
Tekniken för avancerad rening av läkemedelsrester på svenska avloppsreningsverk finns, till en kostnad av cirka en krona per kubikmeter vatten.
-
Vitrolife wants to acquire Medicult
The Swedish company Vitrolife intends to make en exchange offer to the shareholders of the Danish company Medicult to acquire all outstanding shares in the company.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Robotarm till kliniska studier
Forskaren Max Ortiz Catalan, som varit med och tagit fram den första tankestyrda armprotesen med inopererade elektroder, berättar om nästa steg för projektet.
-
”Antibiotikaresistens kan bli nästa stora kris”
Sarah Aiosa började som vd på MSD Sverige mitt under coronapandemin. Hennes ledarstyrka sattes genast på prov då hon fick börja med att krishantera på distans f...
-
New influenza vaccine to EU
The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Danisco first with green emulsifier
A new sustainable emulsifier from Danisco meets the increasing consumer demand for ethically correct consumer goods.
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Medtech giant separates
Due to the global economic situation, the medtech companies Q-Med and the Palomar Medical Technologies has terminated its international agreement.
-
Orion cuts 205 jobs
The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.
-
The winner of the race
She learned how to work hard at an early age and her devotion has certainly paid off. Whether it is field running or running a company, the key to success is fo...